Chunrong Y. Qu

State Key Laboratory Of Drug Research
Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 47 publications

Development of Glycosylated and Dimeric FAP-Targeted Radiotracers for Preclinical Evaluation in FAP-Positive Glioblastoma Models.

Development of Glycosylated and Dimeric FAP-Targeted Radiotracers for Preclinical Evaluation in FAP-Positive Glioblastoma Models.

Journal: Journal of medicinal chemistry
Published: June 25, 2026

Covalent versus Dimeric Optimization of Nectin-4-Targeted Peptide Radiotracers: A Head-to-Head Comparison in Triple-Negative Breast Cancer Mice Models.

Covalent versus Dimeric Optimization of Nectin-4-Targeted Peptide Radiotracers: A Head-to-Head Comparison in Triple-Negative Breast Cancer Mice Models.

Journal: Molecular pharmaceutics
Published: March 26, 2026

Harnessing Insights of Hepatocyte Growth Factor Kringle 3 Domain to Develop c-Met Targeted Positron Emission Tomography Probe.

Harnessing Insights of Hepatocyte Growth Factor Kringle 3 Domain to Develop c-Met Targeted Positron Emission Tomography Probe.

Journal: Journal of medicinal chemistry
Published: December 26, 2025

68Ga-DOTA-TFpep Targeting the Thomsen-Friedenreich Antigen for PET Imaging.

68Ga-DOTA-TFpep Targeting the Thomsen-Friedenreich Antigen for PET Imaging.

Journal: Molecular pharmaceutics
Published: December 15, 2025

A Novel Radiotracer for NTSR1-Targeted PET Imaging of Tumor: Preclinical and First-in-Human Studies.

A Novel Radiotracer for NTSR1-Targeted PET Imaging of Tumor: Preclinical and First-in-Human Studies.

Journal: Journal of medicinal chemistry
Published: November 26, 2025

Construction of 89Zr-Radiolabeled Melanin-Based Nanoprobes with FAP-Targeted Motifs for Tumor PET Imaging.

Construction of 89Zr-Radiolabeled Melanin-Based Nanoprobes with FAP-Targeted Motifs for Tumor PET Imaging.

Journal: Molecular pharmaceutics
Published: October 20, 2025

Development of Dar3A Chelator and Construction of FAP-Targeted PET Probe as Proof of Concept and for First-in-Human Evaluation.

Development of Dar3A Chelator and Construction of FAP-Targeted PET Probe as Proof of Concept and for First-in-Human Evaluation.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: October 07, 2025

Charge modulation in D-A-D molecules: an acid-responsive NIR-II nanoplatform for imaging and photothermal therapy.

Charge modulation in D-A-D molecules: an acid-responsive NIR-II nanoplatform for imaging and photothermal therapy.

Journal: Biomaterials science
Published: October 06, 2025

Development of a Dual-Modal PET/NIR-II Probe of Urofollitropin for Enhanced Follicle-Stimulating Hormone Receptor-Targeted Imaging in Diverse Tumors.

Development of a Dual-Modal PET/NIR-II Probe of Urofollitropin for Enhanced Follicle-Stimulating Hormone Receptor-Targeted Imaging in Diverse Tumors.

Journal: Molecular pharmaceutics
Published: September 16, 2025

ICOS-Targeted Peptide Imaging Informs Therapeutic Response of STING Agonist in Lung Adenocarcinoma.

ICOS-Targeted Peptide Imaging Informs Therapeutic Response of STING Agonist in Lung Adenocarcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: September 04, 2025

Small-Molecule Probe [68Ga]Ga-SMIC-2501 Targeting the V-Domain Immunoglobulin Suppressor of T Cell Activation Protein for Positron Emission Tomography Imaging.

Small-Molecule Probe [68Ga]Ga-SMIC-2501 Targeting the V-Domain Immunoglobulin Suppressor of T Cell Activation Protein for Positron Emission Tomography Imaging.

Journal: Molecular pharmaceutics
Published: June 03, 2025

Design and synthesis of GRPR-targeted PET probes based on Dar derivatives for imaging of prostate cancer.

Design and synthesis of GRPR-targeted PET probes based on Dar derivatives for imaging of prostate cancer.

Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: April 23, 2025
Showing 1-12 of 47

Last Updated: 09/26/2026